Recurrent Adenoid Cystic Carcinoma of the Oral Cavity
Also known as: Recurrent Oral Cavity Adenoid Cystic Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB15243 | 2-(1-Hexyloxyethyl)-2-devinyl pyropheophorbide-a | 1 | Completed | 1 |
| DB01933 | 7-Hydroxystaurosporine | 1 | Completed | 1 |
| DB12442 | Alvespimycin | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 1 | Completed | 1 |
| DB00958 | Carboplatin | 1 | Completed | 1 |
| DB00002 | Cetuximab | 1 | Completed | 2 |
| DB15631 | Edodekin alfa | 1 | Completed | 1 |
| DB00530 | Erlotinib | 1 | Completed | 2 |
| DB01590 | Everolimus | 1 | Completed | 1 |
| DB00099 | Filgrastim | 1 | Completed | 1 |
| DB00544 | Fluorouracil | 1 | Completed | 1 |
| DB01005 | Hydroxyurea | 1 | Completed | 1 |
| DB00762 | Irinotecan | 1 | Completed | 1 |
| DB15721 | Natural Killer Cell | 1 | Completed | 1 |
| DB01229 | Paclitaxel | 1 | Completed | 1 |
| DB00072 | Trastuzumab | 1 | Completed | 1 |
| DB00112 | Bevacizumab | 1 / 2 | Completed | 1 |
| DB00002 | Cetuximab | 1 / 2 | Completed | 1 |
| DB00530 | Erlotinib | 1 / 2 | Completed | 1 |
| DB15107 | Fludeoxyglucose | 1 / 2 | Completed | 1 |
| DB09150 | Fludeoxyglucose (18F) | 1 / 2 | Completed | 1 |
| DB06151 | Acetylcysteine | 2 | Completed | 1 |
| DB00112 | Bevacizumab | 2 | Completed | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB16741 | Bortezomib D-mannitol | 2 | Completed | 1 |
| DB00997 | Doxorubicin | 2 | Completed | 1 |
| DB01259 | Lapatinib | 2 | Completed | 1 |
| DB02546 | Vorinostat | 2 | Completed | 1 |
| DB00317 | Gefitinib | Not Available | Completed | 1 |